Vaccine Against COVID-19 – an Investment Opportunity or a Financial Bubble on the Verge of Popping?

Source: Pixabay

Reading time: six minutes

With over 25 million infected and 844 000 deaths globally, the race for who will first develop a suitable vaccine against the coronavirus is more disputed than ever. At the moment, thousands of investors have flocked to the biotechnological sector where, according to the World Health Organization, as of July there are 173 potential vaccine developers hard at work, while research expenses have reached billions of U.S. dollars.

Read more